
Sign up to save your podcasts
Or


On this week’s Tech Nation, Moira speaks with CEO Dr. Ben Thomas and Chief Commercial Officer Dermot Tierney from Amply Discovery talks about how their novel approach to AI in drug discovery. Then, Dr. Daniel Kraft, the founder and chair of NextMed Health tells us about ChatGPT and Healthcare. And Dr. Alex Pang’s still relevant 2013 interview on smartphones and social media – it’s "The Distraction Addiction."
On this week’s Tech Nation, Moira speaks with CEO Dr. Ben Thomas and Chief Commercial Officer Dermot Tierney from Amply Discovery talks about how their novel approach to AI in drug discovery. Then, Dr. Daniel Kraft, the founder and chair of NextMed Health tells us about ChatGPT and Healthcare. And Dr. Alex Pang’s still relevant 2013 interview on smartphones and social media – it’s "The Distraction Addiction."
On this week’s Tech Nation, Moira speaks with Dr. Sethuraman "Panch" Panchanathan, the Director of the National Science Foundation talks about how they had to pivot during Covid to act fast. Then, in Biotech, with today’s cannabis concentrations, acute cannabis intoxication is on the rise. Dr. Ken Cundy, CSO at Anebulo Pharma is working to create an antidote.
On this week’s Tech Nation, Moira speaks with Dr. Sethuraman "Panch" Panchanathan, the Director of the National Science Foundation talks about how they had to pivot during Covid to act fast. Then, in Biotech, with today’s cannabis concentrations, acute cannabis intoxication is on the rise. Dr. Ken Cundy, CSO at Anebulo Pharma is working to create an antidote.
On this week’s Tech Nation, Moira speaks on the ability to monitor both our health … and our illnesses. Even the ability to see if our medical condition is changing or that last update in prescription really worked. And what about when you travel? Dr. Kal Patel is the Co-Founder and CEO of BrightInsight. He tells us about the challenges and BrightInsight’s solutions. Then speaking of all this new tech, where are we going with all this? David Ewing Duncan’s insights from his 2019 book, “Talking to Robots: Tales from Our Human Robot Future”, are more relevant than ever.
On this week’s Tech Nation, Moira speaks on the ability to monitor both our health … and our illnesses. Even the ability to see if our medical condition is changing or that last update in prescription really worked. And what about when you travel? Dr. Kal Patel is the Co-Founder and CEO of BrightInsight. He tells us about the challenges and BrightInsight’s solutions. Then speaking of all this new tech, where are we going with all this? David Ewing Duncan’s insights from his 2019 book, “Talking to Robots: Tales from Our Human Robot Future”, are more relevant than ever.
On this week’s Tech Nation, Moira speaks with journalist Jason Del Rey about Amazon and Walmart - how they are different and their designs on your attention. His book is “Winner Sells All: Amazon, Walmart, and the Battle for Our Wallets”.
Then in biotech, breakthrough science which changes the name of the game on how to make a medicine. Dr. Sanjay Shukla, the President and CEO of ATyr Pharma, takes this unprecedented approach and ATyr’s first drug candidate which treats pulmonary sarcoidosis.
On this week’s Tech Nation, Moira speaks with journalist Jason Del Rey about Amazon and Walmart - how they are different and their designs on your attention. His book is “Winner Sells All: Amazon, Walmart, and the Battle for Our Wallets”.
Then in biotech, breakthrough science which changes the name of the game on how to make a medicine. Dr. Sanjay Shukla, the President and CEO of ATyr Pharma, takes this unprecedented approach and ATyr’s first drug candidate which treats pulmonary sarcoidosis.
On this week’s Tech Nation, Moira speaks with Dan Levitt, Award-winning documentary producer and Author, “What’s Gotten Into You … The Story of Your Body’s Atoms, from the Big Bang Through Last Night’s Dinner.” Then, in Biotech, we look at progress in Gliobastoma, the most aggressive form of brain cancer. Dr. Fahar Merchant, the President & CEO of Medicenna Therapeutics, joins me to talk about their unprecedented approach to clinical trials.
On this week’s Tech Nation, Moira speaks with Dan Levitt, Award-winning documentary producer and Author, “What’s Gotten Into You … The Story of Your Body’s Atoms, from the Big Bang Through Last Night’s Dinner.” Then, in Biotech, we look at progress in Gliobastoma, the most aggressive form of brain cancer. Dr. Fahar Merchant, the President & CEO of Medicenna Therapeutics, joins me to talk about their unprecedented approach to clinical trials.
From the publisher's feed
TechNation Radio hosted by Dr Moira Gunn

21,811 Listeners

43,833 Listeners

31,931 Listeners

37,882 Listeners

6,789 Listeners

43,334 Listeners

26,822 Listeners

2,856 Listeners

9,185 Listeners

465 Listeners

725 Listeners

922 Listeners

6,430 Listeners

939 Listeners

19 Listeners